CD26

Synonyms

Dipeptidyl peptidase IV membrane form, T-cell activation antigen CD26, Adenosine deaminase complexing protein 2, Dipeptidyl peptidase IV, Dipeptidyl peptidase IV soluble form, ADCP2, Dipeptidyl peptidase 4, ADCP-2, ADABP, DPP4, Dipeptidylpeptidase IV (CD26, Adenosine Deaminase Complexing Protein 2), DPP IV, TP103, CD26, Dipeptidyl-Peptidase 4, Dipeptidylpeptidase 4, CD26 Antigen, DPPIV, Xaa-Pro-Dipeptidylaminopeptidase, Gly-Pro Naphthylamidase, Post-Proline Dipeptidyl Aminopeptidase IV

Description

Dipeptidyl peptidase IV (DPP4), also known as adenosine deaminase complexing protein 2 or CD26 (cluster of differentiation 26) is a protein that, in humans, is encoded by the DPP4 gene.Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by binding at least ADA, CAV1, IGF2R, and PTPRC. Its binding to CAV1 and CARD11 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. Its interaction with ADA also regulates lymphocyte-epithelial cell adhesion. In association with FAP is involved in the pericellular proteolysis of the extracellular matrix (ECM), the migration and invasion of endothelial cells into the ECM. May be involved in the promotion of lymphatic endothelial cells adhesion, migration and tube formation. When overexpressed, enhanced cell proliferation, a process inhibited by GPC3. Acts also as a serine exopeptidase with a dipeptidyl peptidase activity that regulates various physiological processes by cleaving peptides in the circulation, including many chemokines, mitogenic growth factors, neuropeptides and peptide hormones. Removes N-terminal dipeptides sequentially from polypeptides having unsubstituted N-termini provided that the penultimate residue is proline.

KO Status

RenMab: In Vivo

Drug Information

Launched drugs: 33
Drugs in clinical trials: 24
Latest Research Phase: Approved

Drug Name

Code

Phase

Company

Indications

Clinical Trials

Omarigliptin

MK-3102

Approved

Merck & Co Inc

Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic

Sitagliptin/Ertugliflozin

Approved

Pfizer Pharmaceuticals Ltd (China)

Diabetes Mellitus, Type 2

Sitagliptin Phosphate Monohydrate

MK-431, MK-0431, ONO-5435, ONO-5435A, L-000224715

Approved

Merck Sharp & Dohme Corp

Diabetes Mellitus, Type 2, Renal Insufficiency, Glucose Intolerance, Dyslipidemias, Hepatic Insufficiency, Kidney Failure, Chronic, Diabetes Mellitus

Gemigliptin L-tartrate Sesquihydrate

LC-150444, LC-15-0444

Approved

Lg Life Sciences Ltd

Diabetes Mellitus, Type 2, Hepatic Insufficiency

Saxagliptin Hydrate

OPC-262, BMS-477118, BMS-477118-11

Approved

Bristol-Myers Squibb Company

Diabetes Mellitus, Type 2, Diabetes Mellitus

Alogliptin Benzoate/Pioglitazone Hydrochloride

SYR-322-4833 BL

Approved

Takeda Pharmaceutical Co Ltd

Diabetes Mellitus, Type 2

Teneligliptin Hydrobromide Hydrate/Metformin Hydrochloride

Approved

Handok Inc

Diabetes Mellitus, Type 2

Alogliptin Benzoate

SYR-322, TAK-322

Approved

Takeda

Diabetes Mellitus, Type 2, Acute Coronary Syndrome, Diabetes Mellitus

Sitagliptin Phosphate Monohydrate/Ipragliflozin L-Proline

MK-0431J

Approved

Merck & Co Inc, Astellas Pharma Inc

Diabetes Mellitus, Type 2

Evogliptin Tartrate/Metformin Hydrochloride

DA-1229_01

Approved

Dong-A Pharmaceutical Co Ltd

Diabetes Mellitus, Type 2

References

Title

Authors

Source

Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes

Cordero O.J., Salgado F.J., Vinuela J.E., Nogueira M.,

Immunobiology 197:522-533(1997)

Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity

Abbott C.A., McCaughan G.W., Gorrell M.D.,

FEBS Lett. 458:278-284(1999)

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

Park J.E., Lenter M.C., Zimmermann R.N., Garin-Chesa P., Old L.J., Rettig W.J.,

J. Biol. Chem. 274:36505-36512(1999)

Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer

Cordero O.J., Ayude D., Nogueira M., Rodriguez-Berrocal F.J., de la Cadena M.P.,

Br. J. Cancer 83:1139-1146(2000)

Mechanisms of CD26/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes

Salgado F.J., Vela E., Martin M., Franco R., Nogueira M., Cordero O.J.,

Cytokine 12:1136-1141(2000)

Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry

Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.,

J. Proteome Res. 8:651-661(2009)

Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation

Ikushima H., Munakata Y., Ishii T., Iwata S., Terashima M., Tanaka H., Schlossman S.F., Morimoto C.,

Proc. Natl. Acad. Sci. U.S.A. 97:8439-8444(2000)

Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction

Gines S., Marino M., Mallol J., Canela E.I., Morimoto C., Callebaut C., Hovanessian A., Casado V., Lluis C., Franco R.,

Biochem. J. 361:203-209(2002)

Intestinal dipeptidyl peptidase IV is efficiently sorted to the apical membrane through the concerted action of N- and O-glycans as well as association with lipid microdomains

Alfalah M., Jacob R., Naim H.Y.,

J. Biol. Chem. 277:10683-10690(2002)

A role for interleukin-12 in the regulation of T cell plasma membrane compartmentation

Salgado F.J., Lojo J., Alonso-Lebrero J.L., Lluis C., Franco R., Cordero O.J., Nogueira M.,

J. Biol. Chem. 278:24849-24857(2003)

What's Next for the RenMice™ HiTS Platform?

Please stay tuned for the latest progress of our RenMice™ HiTS Platform. We are open to co-development programs to discover novel antibody therapeutics.
Please contact our team if you are interested in learning more about the HiTS Platform or would like to explore partnership.